What is the annual cost of ACL injury in the United States?

What is the annual cost of ACL injury in the United States?

• A. 3 Billion
• B. 5 Billion
• C. 7 Billion
• D. 10 Billion

Answer: (B)

The main idea is the overall economic burden of ACL injuries, which includes both the medical costs of treatment and the broader societal costs from recovery and long-term impact. ACL tears typically require surgery (reconstruction), preoperative workups, imaging, anesthesia, and extensive rehabilitation. In addition, there are indirect costs such as days off work, lost productivity, and the potential for longer-term issues like knee osteoarthritis that drive further medical expenses over time. When these direct and indirect costs are tallied across all new injuries each year in the United States, the total comes to about five billion dollars. That figure sits between lower estimates that focus only on immediate medical expenses and higher estimates that push into long-term costs; it best reflects the full annual burden commonly cited in analyses. The lower option would underestimate the scope of care and recovery, while the higher options would overstate it for typical national cost assessments.

The main idea is the overall economic burden of ACL injuries, which includes both the medical costs of treatment and the broader societal costs from recovery and long-term impact. ACL tears typically require surgery (reconstruction), preoperative workups, imaging, anesthesia, and extensive rehabilitation. In addition, there are indirect costs such as days off work, lost productivity, and the potential for longer-term issues like knee osteoarthritis that drive further medical expenses over time. When these direct and indirect costs are tallied across all new injuries each year in the United States, the total comes to about five billion dollars. That figure sits between lower estimates that focus only on immediate medical expenses and higher estimates that push into long-term costs; it best reflects the full annual burden commonly cited in analyses. The lower option would underestimate the scope of care and recovery, while the higher options would overstate it for typical national cost assessments.